1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Drug Safety and Risk Management Advisory Committee
  6. Drug Safety and Risk Management Advisory Committee Roster
  1. Drug Safety and Risk Management Advisory Committee

Drug Safety and Risk Management Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies = 6
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson
Vacant

Designated Federal Officer (Vacant)
Jessica Seo, PharmD, MPH
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
(301) 796-9001 Fax: (301) 847-8533
E-mail: DSaRM@fda.hhs.gov

 

Maryann Amirshahi PharmD, MD, MPH, PhD, BCPS, FACMT, FACEP, FASAM, FCP
Expertise: Emergency Medicine, Medical Toxicology, Addiction Medicine, Clinical Pharmacology
Term: 10/31/2024 – 5/31/2028
Professor of Emergency Medicine,
Georgetown University School of Medicine
Department of Emergency Medicine,
MedStar Washington Hospital Center
110 Irving Street NW
Washington, District of Columbia 20010

Michael C. Dejos, PharmD, MBA, BCPS, CHOP, CPPS
Expertise: Patient Safety, Pharmacovigilance, Continuous Improvement
Term: 9/20/2023 – 5/31/2027
System Medication Safety Officer
Methodist Le Bonheur Healthcare
Assistant Professor
University of Tennessee Health Science Center
1211 Union Avenue, Suite 640
Memphis, Tennessee 38104

Sascha Dublin, MD, PhD
Expertise: Internal Medicine, Pharmacoepidemiology
Term: 6/1/2022 – 5/31/2026
Senior Scientific Investigator
Kaiser Permanente Washington Health Research Institute 
1730 Minor Avenue, Suite 1360
Seattle, Washington 98101 

James Floyd, MD, MS
Expertise: Epidemiology, Internal Medicine
Term: 6/1/2022– 5/31/2026
Co-Director, Cardiovascular Health Research Unit
Professor of Medicine
Adjunct Professor of Epidemiology
University of Washington
4333 Brooklyn Ave NE
Seattle, Washington 98195

Elizabeth Rebo, PharmD, MBA, CPPS
Expertise: Medication Safety
Term: 10/31/2024 – 5/31/2028
Executive Director, Pharmacy Quality and Medication Safety
National Pharmacy Services
Kaiser Permanente
12254 Bellflower Blvd
Downey, California 90242

**Ignacio Rodriguez, MD
Expertise: Drug Development, Clinical Safety and Risk Management
Term: 6/11/2024 – 10/31/2027
Vice President, Global Head Medical Safety
Novartis Pharmaceuticals Corporation
1 Health Plaza
East Hanover, New Jersey 07936

+Jens-Ulrich Stegmann, RN, MD
Expertise: Clinical Development, Clinical Safety, Pharmacovigilance and Risk Management
Term: 6/11/2024 – 10/31/2027
Senior Vice President
Global Head Clinical Safety and Pharmacovigilance, EU QPPV
GlaxoSmithKline (GSK)
20 Avenue Fleming
Wavre, Belgium

* Consumer Representative (Vacant)
**Industry Representative (non-voting)
+Alternate Industry Representative (non-voting)

Updated:  September 11, 2025

Back to Top